Eris Lifesciences Ltd - APPOINTMENT OF MS. KALPANA UNADKAT AS AN ADDITIONAL INDEPENDENT DIRECTOR OF<BR> THE COMPANY

In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure<BR> Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform you that based on the recommendation of<BR> the Nomination and Remuneration Committee and their own consideration, the Board of Directors have approved the<BR> appointment of Ms. Kalpana Unadkat (DIN : 02490816) as an 'Additional Director (Non-Executive Independent<BR> Director)' on the Board of the Company for a term of 5 (five) years starting from 5th January, 2021, by means of a<BR> circular resolution on 5th January 2021. The said appointment is subject to approval of the general body, in the usual<BR> course.